INDIVIOR LIMITED

09237894
Active Hull

Activities of other holding companies n.e.c.

0 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
I

INDIVIOR LIMITED

09237894

Activities of other holding companies n.e.c.

Founded 26 Sept 2014 Active Hull, United Kingdom 0 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

INDIVIOR PLC 26 Sept 2014 — 3 Feb 2026
Accounts Due 30 Jun 2026 13 days remaining
Confirmation Submitted 25 Feb 2026 Next due 10 Mar 2027 8 months remaining
Net assets £-98M £65M 2025 year on year
Total assets £1,201M £32M 2025 year on year
Total Liabilities £1,299M £33M 2025 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

Indivior Dansom Lane Hull HU8 7DS United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for INDIVIOR LIMITED (09237894), an active life sciences and medical technology company based in Hull, United Kingdom. Incorporated 26 Sept 2014. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type group
Next accounts 31 Dec 2025
Due by 30 Jun 2026 13 days remaining

Balance Sheet & P&L (2013–2025)

Cash in Bank

£195.00M

Decreased by £60.07M (-24%)

Net Assets

-£98.00M

Increased by £65.41M (+40%)

Total Liabilities

£1299.00M

Decreased by £32.95M (-2%)

Turnover

£1242.00M

Increased by £295.05M (+31%)

Employees

N/A

Debt Ratio

108%

Decreased by 6 (-5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

59 Allotments 19,202,243 Shares £12.88m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Oct 2025145$2k$13.4
28 Oct 2025101$101$101
28 Oct 2025287$3k$9.4
16 Oct 202550,000$25k$0.5
26 Aug 2025191$2k$9.4

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Indivior Us Intermediate 2, Inc. 10710 Midlothian Turnpike Suite 125 North Chestfield Va 23235
100.0%
125,065,242

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Indivior Pharmaceuticals, Inc.

Unknown

Active
Notified 23 Jan 2026
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent

Group Structure

Group Structure

INDIVIOR LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026Persons With Significant ControlIndivior Pharmaceuticals, Inc. notified as a person with significant control
25 Feb 2026Confirmation StatementConfirmation statement made on 24 Feb 2026 with updates
17 Feb 2026MiscellaneousCourt Order
17 Feb 2026MiscellaneousMiscellaneous
17 Feb 2026CapitalCapital Statement Capital Company With Date Currency Figure
26 Feb 2026 Persons With Significant Control

Indivior Pharmaceuticals, Inc. notified as a person with significant control

25 Feb 2026 Confirmation Statement

Confirmation statement made on 24 Feb 2026 with updates

17 Feb 2026 Miscellaneous

Court Order

17 Feb 2026 Miscellaneous

Miscellaneous

17 Feb 2026 Capital

Capital Statement Capital Company With Date Currency Figure

Recent Activity

Latest Activity

Indivior Pharmaceuticals, Inc. notified as a person with significant control

3 months ago on 26 Feb 2026

Confirmation statement made on 24 Feb 2026 with updates

3 months ago on 25 Feb 2026

Court Order

3 months ago on 17 Feb 2026

Miscellaneous

3 months ago on 17 Feb 2026

Capital Statement Capital Company With Date Currency Figure

3 months ago on 17 Feb 2026